SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neogen Chemicals Ltd (NEOGEN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542665 NSE: NEOGEN Chemicals | Small Cap | Neogen Chemicals Share Price

₹1,940.95 14.20 (0.74%)

As on 24-Jun'26 16:59

Neogen Chemicals Ltd (NEOGEN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542665 NSE: NEOGEN Chemicals | Small Cap | Neogen Chemicals Share Price

₹1,940.95 14.20 (0.74%)

As on 24-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹5,315 Cr.
Current Price
₹1,941
52-Week Low / High
₹978 / 2,100
TTM EPS
₹17.2
TTM Sales
₹855 Cr.
Book Value per Share
₹370.6
P/E Ratio
113.17
Higher than its 5-year historical median
Industry PE
52.2
Price to Book (P/B)
5.24
Lower than its 5-year historical median
Price to Sales (P/S)
6.21
Higher than its 5-year historical median
EV/EBITDA
35.81
In line with its 5-year historical median
Dividend Yield
0.05%
Profitability Efficiency
Return on Equity (ROE)
6.15%
Underperforms industry median
Return on Capital Employed (ROCE)
9.76%
Underperforms industry median
Return on Assets (ROA)
3.20%
Operating Profit Margin
19%
Net Profit Margin
6.26%
Gross Profit Margin
13.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
11.1%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
26.62%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
17.7%
Asset Quality
Promoter Holding
51.23%
Pledged shares (%) of Promoter's holding (%)
9.76%
Reserves
₹987 Cr.
Equity
₹27.4 Cr.
Face Value
₹10
All Time Low / High
₹240.55 / 2414.90

Neogen Chemicals stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Neogen Chemicals Ltd a good quality company?
Neogen Chemicals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Neogen Chemicals Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Neogen Chemicals Ltd vs industry peers?
Neogen Chemicals Ltd revenue CAGR is 20.37%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Neogen Chemicals Ltd?
Promoters hold 51.23% of the Neogen Chemicals Ltd, with 9.76% of their stake pledged, indicating low pledge risk.
Q.1 Stock return of Neogen Chemicals Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 11.68% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Neogen Chemicals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 26.1%23.1%22.9%25.5%21.9%16.8%14.3%13.3%10.1%9.8%-
Value Creation
Index
0.90.70.70.80.60.20.0-0.1-0.3-0.3-

Growth Parameters

Sales 100110161239306336487686696774855
Sales YoY Gr.-9.7%46.4%48.4%28.1%9.9%44.8%40.8%1.5%11.1%-
Adj EPS 2.63.85.210.512.313.417.92016.721.917.2
YoY Gr.-47.1%35.4%103.7%17%8.6%33.8%12.1%-16.8%31.3%-
BVPS (₹) 13.82125.335.167.278.5176.2193.5290.2306.6370.6
Adj Net
Profit
5.27.610.321.128.731.244.6504457.847
Cash Flow from Ops. 8.60.311.8-3.8-34.183.31.2-30.4-115199-
Debt/CF from Ops. 3.1264.67-31.8-42.6187.3-11.9-3.32.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 25.5%20.4%16.7%11.1%
Adj EPS 26.8%12.2%7%31.3%
BVPS41.2%35.5%20.3%5.7%
Share Price - 18.4% 5.8% 16.3%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
20.321.922.334.925.318.414.310.87.17.35.1
Op. Profit
Mgn %
14.118.21818.31919.117.816.316.61917.7
Net Profit
Mgn %
5.26.96.48.89.49.39.27.36.37.55.5
Debt to
Equity
11.61.61.70.91.20.50.80.50.60.3
Working Cap
Days
189227224193211223235253400505247
Cash Conv.
Cycle
6769908612210811213020017468

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales100110161239306336487686701774
Operating Expenses + 8690132196248272401575585627
Manufacturing Costs12132130344273938889
Material Costs616495141184198275389395423
Employee Cost 55911172032475758
Other Costs 98714131322464556
Operating Profit 14202943586487112116147
Operating Profit Margin (%) 14.1%18.2%18.0%18.2%19.0%19.1%17.8%16.3%16.6%19.0%
Other Income + 00110115810
Exceptional Items 000000000-14
Interest 581012121419294251
Depreciation 11235712162326
Profit Before Tax 8121829414457715966
Tax 3478121312211818
Profit After Tax 581121293145504148
PAT Margin (%) 5.2%7.0%6.6%8.8%9.4%9.4%9.2%7.3%5.9%6.3%
Adjusted EPS (₹)2.63.95.410.512.313.517.920.115.618.4
Dividend Payout Ratio (%)17.40%0%18.70%14.30%16.20%16.70%15.30%15%12.80%5.50%

Valuation of Neogen Chemicals - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 28425170157183439483766809
Share Capital 20202020232325252626
Reserves 8223150133160414458740782
Debt +256780116132202198333367400
Long Term Debt53738513011612212912448
Short Term Debt203041651028676204243352
Minority Interest0000000000
Trade Payables22313743366699157145255
Others Liabilities 612141830416481127158
Total Liabilities 801521812473554928001,0541,4051,621

Fixed Assets

Net Fixed Assets +17566783111127285347361228
Gross Block20606988120144313390428299
Accumulated Depreciation2325101728426871
CWIP 1110311511365628
Investments 00000081775193
Inventories32405072130114195293382306
Trade Receivables163241617579110177282199
Cash Equivalents 232211452120
Others Assets 12191928355673103317667
Total Assets 801521812473554928001,0541,4051,621

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 9012-4-34831-30-134199
PBT 8121829414457715966
Adjustment 671217221324465687
Changes in Working Capital -3-15-14-45-8537-70-136-24058
Tax Paid -3-4-4-6-13-10-10-12-10-12
Cash Flow From Investing Activity + -4-33-13-20-29-134-146-94-129-188
Capex -5-33-14-18-27-23-170-104-73-32
Net Investments 0-100000000
Others 001-2-2-111249-55-156
Cash Flow From Financing Activity + -433-0246251188100226-12
Net Proceeds from Shares -000070022502470
Net Proceeds from Borrowing 0191381700000
Interest Paid -4-6-8-10-12-14-19-29-43-51
Dividend Paid -1-0-3-2-4-5-5-7-7-5
Others 22110-2-869-121363044
Net Cash Flow 01-10-1-044-25-37-2

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)20.322.2823.0934.7625.3318.514.3710.866.596.15
ROCE (%)26.1123.1322.9225.5421.9416.7714.3413.2610.129.76
Asset Turnover Ratio1.461.040.991.21.150.950.750.740.570.51
PAT to CFO Conversion(x)1.801.09-0.19-1.172.680.02-0.6-3.274.15
Working Capital Days
Receivable Days56.7072.1081.8072.9071.407070.4076.30118.90113
Inventory Days94107.80100.2087.40106.20111.10115.60129.70174.40161.50
Payable Days114.10150.50130.20103.107894.10109.50120139.40172.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.009.76
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Neogen Chemicals Ltd FAQs

The current trading price of Neogen Chemicals on 24-Jun-2026 16:59 is ₹1,941.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Neogen Chemicals stood at ₹5,314.7 Cr

The latest P/E ratio of Neogen Chemicals as of 23-Jun-2026 is 113.2.

The latest P/B ratio of Neogen Chemicals as of 23-Jun-2026 is 5.24.

The 52-week high of Neogen Chemicals is ₹2,099.8 and the 52-week low is ₹978.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Neogen Chemicals is ₹855 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Neogen Chemicals Ltd is a average quality company.

The key valuation ratios of Neogen Chemicals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Neogen Chemicals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Neogen Chemicals Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: